Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 29,615 | 30,028 | 26,557 | 27,630 | 23,457 |
| Cost of Goods | 16,854 | 12,627 | 14,717 | 16,175 | 11,355 |
| Gross Profit | 12,761 | 17,401 | 11,840 | 11,455 | 12,102 |
| Operating Expenses | 46,678 | 38,383 | 54,439 | 61,128 | 75,380 |
| Operating Income | -33,063 | -20,355 | -41,882 | -49,498 | -62,923 |
| Other Income | 295 | 486 | -26 | -6,861 | -965 |
| Pre-tax Income | -32,768 | -19,869 | -41,908 | -56,359 | -63,888 |
| Net Income Continuous | -32,768 | -19,869 | -41,908 | -56,359 | -63,888 |
| Net Income | $-32,768 | $-19,869 | $-41,908 | $-56,359 | $-63,888 |
| EPS Basic Total Ops | -0.27 | -0.11 | -0.38 | -0.55 | -0.63 |
| EPS Basic Continuous Ops | -0.27 | -0.12 | -0.38 | -0.55 | -0.63 |
| EPS Diluted Total Ops | -0.27 | -0.11 | -0.38 | -0.55 | -0.63 |
| EPS Diluted Continuous Ops | -0.27 | -0.12 | -0.38 | -0.55 | -0.63 |
| EBITDA(a) | $-32,768 | $-20,088 | $-41,379 | $-48,788 | $-62,048 |